Monoclonal antibody specific to HA2 glycopeptide protects mice from H3N2 influenza virus infection
Open Access
- 19 March 2015
- journal article
- research article
- Published by Springer Nature in Veterinary Research
- Vol. 46 (1) , 33
Abstract
Canine influenza virus (CIV) subtype H3N2 is a newly identified, highly contagious respiratory pathogen that causes cough, pneumonia and other respiratory symptoms in dogs. Data indicate that the virus is responsible for recent clinical cases of dog disease in China. However, therapeutic options for this disease are very limited. In this study, seven monoclonal antibodies (mAbs) against CIV JS/10 (an H3N2 subtype virus) were produced and characterized. Among them, mAb D7, which is specific for the HA2 glycopeptide (gp), induced the highest neutralization titers. The protection provided by mAb D7 was evaluated in BALB/c mice challenged with homologous or heterologous strains of H3N2 influenza virus, including two strains of CIV and one strain of swine influenza virus (SIV). The data show that mAb D7 protected the mice from infection with the three viral strains, especially the homologous strain, which was indicated by the recovery of body weight, reduction of viral load, and reduction of tissue damage. Moreover, the levels of IFN-γ and TNF-α in the lungs, as detected by ELISA, were reduced in the infected mice treated with the mAb D7 compared with those without mAb D7 treatment. Thus, our findings demonstrate, for the first time, that a mAb could reduce the release of IFN-γ and TNF-α associated with tissue damage by CIV infection and that the mAb might be of great therapeutic value for CIV infection.Keywords
This publication has 55 references indexed in Scilit:
- Immunopathogenic and Antibacterial Effects of H3N2 Influenza A Virus PB1-F2 Map to Amino Acid Residues 62, 75, 79, and 82Journal of Virology, 2011
- Pandemic and Seasonal Human Influenza Virus Infections in Domestic Cats: Prevalence, Association with Respiratory Disease, and Seasonality PatternsJournal of Clinical Microbiology, 2011
- Cross-Protection of Chicken Immunoglobulin Y Antibodies against H5N1 and H1N1 Viruses Passively Administered in MiceClinical and Vaccine Immunology, 2011
- Avian-origin H3N2 canine influenza A viruses in Southern ChinaInfection, Genetics and Evolution, 2010
- Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre studyBMJ, 2010
- Monoclonal Antibodies against the Fusion Peptide of Hemagglutinin Protect Mice from Lethal Influenza A Virus H5N1 InfectionJournal of Virology, 2009
- Alveolar Macrophages Are Indispensable for Controlling Influenza Viruses in Lungs of PigsJournal of Virology, 2008
- Antigenic Profile of Avian H5N1 Viruses in Asia from 2002 to 2007Journal of Virology, 2008
- Inhibition of the cytokine response does not protect against lethal H5N1 influenza infectionProceedings of the National Academy of Sciences, 2007
- Role of Host Cytokine Responses in the Pathogenesis of Avian H5N1 Influenza Viruses in MiceJournal of Virology, 2007